ASNS Market Cap History
Below is a table of the ASNS market cap history going back to 11/16/2017:

Date ASNS Market Cap

Also see: ASNS Shares Outstanding History
and ASNS YTD Return
ASNS Historical Market Cap:
-94.41% CAGR
ASNS Historical Market Cap: +-94.41% CAGR

Mouse over chart for data details
X4 Pharmaceuticals is a clinical-stage biopharmaceutical company focused on applying monoclonal antibody immunotherapies for infectious diseases. Co.'s key product candidate, ASN100, is a monoclonal antibody therapeutic in clinical development for the prevention of Staphylococcus aureus pneumonia. Co.'s preclinical pipeline is comprised of monoclonal antibodies (mAbs) targeting multiple serious bacterial and viral pathogens, including respiratory syncytial virus (RSV). Co.'s ASN500 program is comprised of mAbs targeting RSV, which Co. is developing for the prevention of RSV infection. Co.'s Gram-negative programs include ASN300 for Klebsiella pneumoniae and ASN200 for Escherichia coli. We show 5 historical shares outstanding datapoints in our ASNS shares outstanding history coverage, used to compute ASNS market cap on those dates.

Understanding the changing numbers of shares outstanding, the changing share price, and the resulting changing ASNS market cap history over the course of time is important for investors interested in comparing ASNS's market cap history versus its peers. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies, and then calculating their respective market caps. Comparing the share price of ASNS versus a peer is one thing; comparing ASNS market cap versus a peer is a completely different story. Furthermore, via fluctuation both in per-share price and in the number of shares outstanding (via issuance of new shares over time, the repurchase of existing shares), the market cap for a company like ASNS can fluctuate over the course of history. With this page we aim to empower investors researching ASNS by allowing them to research the ASNS market cap history.
Quotes delayed 20 minutes
Get Free SEC filing alerts for ASNS:
ASNS SEC Filing Email Alerts ServiceExternal link
10 Most Oversold Stocks in the S&P
10 Most Overbought Stocks in the S&P
10 ETFs With Stocks That Insiders Are Buying
10 ETFs With Most Upside To Analyst Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Energy Stocks You Can Buy Cheaper Than Insiders Did
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active Call & Put Options of the S&P 500 Components
Video: The Importance of Market Cap

If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Arsanis (ASNS) is categorized under the Healthcare sector; to help you further research historical market cap numbers, below are some other companies in the same sector:

ATEC Market Cap History
ATHX Market Cap History
ATNX Market Cap History
ATOS Market Cap History
ATRA Market Cap History
ATRC Market Cap History
ATRI Market Cap History
ATRS Market Cap History
ATXI Market Cap History
AVEO Market Cap History
More Healthcare companies »


ASNS Market Cap History | | Copyright © 2017 - 2020, All Rights Reserved

Nothing in is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.